High TTN‐AS1 expression significantly correlates with shorter OS, adverse DFS, lymph node metastases, larger tumor size, worse differentiation, and more advanced tumor stage when compared with low TTN‐AS1 expression. This evidence concerns the gene TTN and neoplasm.